Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1264-1272

  Ustun, Funda ^a   Durmus Altun, Gülay ^b   Altaner, Semsi ^b   Tuncbilek, Nermin ^b   Uzal, Cem ^b   Berkarda, Sakir ^b  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

99mTc Tetrofosmin; Angiogenesis; Doppler sonography; Microvessel density; Morphine

Indexed keywords

MORPHINE SULFATE; TETROFOSMIN TC 99M;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; MICROVASCULATURE; MICROVESSEL DENSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SCINTISCANNING; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, EHRLICH TUMOR; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MORPHINE; NARCOTICS; NEOVASCULARIZATION, PATHOLOGIC; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; ULTRASONOGRAPHY, DOPPLER;

EID: 80052365486     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9573-5     Document Type: Article

References (51)

1. B Higley FW Smith T Smith HG Gemmell P Das Gupta 1993 Technetium-99 m-1, 2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent J Nucl Med 34 30 38
2. PF Rambaldi L Mansi E Procaccini F Di Gregorio E Del Vecchio 1995 Breast cancer detection with Tc-99 m tetrofosmin Clin Nucl Med 20 703 705
3. M Klain S Maurea S Lastoria A Cuocolo A Colao 1995 Technetium-99 m-tetrofosmin imaging of differentiated mixed thyroid cancer J Nucl Med 36 2248 2251
4. T Basoglu M Sahin C Coskun A Koparan I Bernay 1995 Technetium-99 m-tetrofosmin uptake in malignant lung tumours Eur J Nucl Med 22 687 689
5. M Rodrigues F Chehne W Kalinowska P Berghammer C Zielinski 2000 Uptake of 99 mTc-MIBI and 99 mTc-tetrofosmin into malignant versus nonmalignant breast cell lines J Nucl Med 41 1495 1499
6. TJ Liu TJ YC Shiau SC Tsai JJ Wang ST Ho 2003 Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99 m tetrofosmin mammoscintigraphy Breast 12 58 62
7. D Fuster N Viñolas C Mallafré J Pavia F Martín 2003 Tetrofosmin as predictors of tumour response Q J Nucl Med 47 58 62
8. JH Yoon HS Bom HC Song JH Lee YJ Jaegal 1999 Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer Clin Nucl Med 24 314 318
9. JN Lickiss 2001 Approaching cancer pain relief Eur J Pain 5 Suppl A 5 14
10. N Sueoka E Sueoka S Okabe H Fujiki 1996 Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression Carcinogenesis 17 2337 2341
11. R Maneckjee JD Minna 1994 Opioids induce while nicotine suppresses apoptosis in human lung cancer cells Cell Growth Differ 5 1033 1040
12. R Maneckjee JD Minna 1990 Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines Proc Natl Acad Sci USA 87 3294 3298
13. A Pasi BX Qu R Steiner HJ Senn W Bär 1991 Angiogenesis: modulation with opioids Gen Pharmacol 22 1077 1079
14. A Hatzoglou L Ouafik E Bakogeorgou K Thermos E Castanas 1995 Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth Cancer Res 55 5632 5636
15. A Hatzoglou E Bakogeorgou E Castanas 1996 The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors Eur J Pharmacol 296 199 207
16. R Maneckjee R Biswas BK Vonderhaar 1990 Binding of opioids to human MCF-7 breast cancer cells and their effects on growth Cancer Res 50 2234 2238
17. M Kampa E Bakogeorgou A Hatzoglou A Damianaki PM Martin 1997 Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors Eur J Pharmacol 335 255 265
18. I Tegeder S Grösch A Schmidtko A Häussler H Schmidt 2003 G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation Cancer Res 63 1846 1852
19. MP Yeager TA Colacchio 1991 Effect of morphine on growth of metastatic colon cancer in vivo Arch Surg 126 454 456
20. T Sasamura S Nakamura Y Iida H Fujii J Murata 2002 Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation Eur J Pharmacol 441 185 191
21. Y Harimaya K Koizumi T Andoh H Nojima Y Kuraishi 2002 Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells Cancer Lett 187 121 127
22. RH Simon TE Arbo 1986 Morphine increases metastatic tumor growth Brain Res Bull 16 363 367
23. JW Lewis Y Shavit GW Terman LR Nelson RP Gale 1983 Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth Peptides 4 635 638
24. MG Sergeeva ZV Grishina SD Varfolomeyev 1993 Morphine effect on proliferation of normal and tumor cells of immune origin Immunol Lett 36 215 218
25. K Gupta S Kshirsagar L Chang R Schwartz PY Law 2002 Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth Cancer Res 62 4491 4498
26. M Farooqui Y Li T Rogers T Poonawala RJ Griffin 2007 COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia Br J Cancer 97 1523 1531
27. X Zhu H Wu J Xia M Zhao Z Xianyu 2002 The relationship between (99m)Tc-MIBI uptakes and tumor cell death/proliferation state under irradiation Cancer Lett 182 217 222
28. F Ustun G Durmus-Altun Z Cukur S Altaner S Berkarda 2009 Glucose-induced alteration of accumulation of organotechnetium complexes accumulation in Pgp-negative tumor-bearing mice Cancer Biother Radiopharm 24 333 338
29. SK Benerjee MN Zoubime M Mullick AP Weston R Cherian 2000 Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations Pankreas 20 248 255
30. PA Singleton MW Lingen MJ Fekete JG Garcia J Moss 2006 Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation Microvasc Res 72 3 11
31. R Arerangaiah N Chalasani AM Udager ML Weber JC Manivel 2007 Opioids induce renal abnormalities in tumor-bearing mice Nephron Exp Nephrol 105 e80 e89
32. DO Freier BA Fuchs 1994 A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity J Pharmacol Exp Ther 270 1127 1133
33. JA Glasel 2000 The effects of morphine on cell proliferation Prog Drug Res 55 33 80
34. PK Peterson TW Molitor CC Chao 1993 Mechanisms of morphine-induced immunomodulation Biochem Pharmacol 46 343 348
35. M Ishikawa K Tanno A Kamo Y Takayanagi K Sasaki 1993 Enhancement of tumor growth by morphine and its possible mechanism in mice Biol Pharm Bull 16 762 766
36. DJ Carr M Serou 1995 Exogenous and endogenous opioids as biological response modifiers Immunopharmacology 31 59 71
37. K Fecho KA Maslonek LA Dykstra DT Lysle 1996 Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats J Pharmacol Exp Ther 277 633 645
38. GB Stefano A Hartman TV Bilfinger HI Magazine Y Liu 1995 Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation J Biol Chem 270 30290 30293
39. E Fosslien 2000 Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia Crit Rev Clin Lab Sci 37 431 502
40. N Locopo M Fanelli G Gasparini 1998 Clinical significance of angiogenic factors in breast cancer Breast Cancer Res Treat 52 159 173
41. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature 407 249 257
42. SW Kim SS Park SJ Ahn KW Chung WK Moon 2002 Identification of angiogenesis in primary breast carcinoma according to the image analysis Breast Cancer Res Treat 74 121 129
43. I Adalet MO Demirkol M Müslümanoǧlu Y Bozfakioǧlu S Cantez 1997 99Tcm-tetrofosmin scintigraphy in the evaluation of palpable breast masses Nucl Med Commun 18 118 121
44. AS Arbab K Koizumi K Toyama T Araki 1996 Uptake of technetium-99m- tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines J Nucl Med 37 1551 1556
45. R Taillefer 1999 The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis Semin Nucl Med 29 16 40
46. IJ Kim SJ Kim YK Kim 2008 Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses Neoplasma 55 526 531
47. H Ohira K Kubota N Ohuchi Y Harada H Fukuda 2000 Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models J Nucl Med 41 1561 1568
48. Ballinger JR. 99mTc-tetrofosmin for functional imaging of P-glycoprotein modulation in vivo. J Clin Pharmacol. 2001 Jul;Suppl:39S-47S.
49. WS Chen KE Luker JL Dahlheimer CM Pica GD Luker 2000 Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin Biochem Pharmacol 60 413 426
50. T Márián G Szabó K Goda H Nagy N Szincsák 2003 In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance Eur J Nucl Med Mol Imaging 30 1147 1154
51. SB Fox DG Generali AL Harris 2007 Breast tumour angiogenesis Breast Cancer Res 9 216